Analyst Consensus ?
ConsensusHold35 ratings
Bullish822.8%
Neutral2468.6%
Bearish38.6%
FN2 Earnings Intelligence
The Hershey Company analyst ratings
The Hershey Company (HSY) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$183.91Previous close
$129.11Low
$215.81Average
$260High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Stifel | Hold | Hold | Maintain | Jul 22, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 21, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 16, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 13, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 9, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jun 25, 2026 |
| Mizuho | Neutral | Neutral | Maintain | May 20, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | May 4, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 1, 2026 |
| TD Cowen | Buy | Hold | Upgrade | May 1, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 23, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Feb 3, 2026 |
| Jefferies | Neutral | Neutral | Maintain | Feb 2, 2026 |
| Goldman Sachs | Buy | Sell | Upgrade | Sep 16, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Apr 15, 2025 |
| Bernstein | Market Perform | Outperform | Downgrade | Oct 7, 2024 |
| Argus Research | Hold | Buy | Downgrade | Aug 14, 2024 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Mar 26, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 3, 2023 |
| Cowen & Co. | Perform | Market Perform | Maintain | Sep 14, 2022 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 29, 2022 |
| CFRA | Sell | Hold | Downgrade | Apr 23, 2020 |
| Edward Jones | Buy | Hold | Upgrade | Mar 25, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Dec 20, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 26, 2019 |
| Piper Jaffray | Underweight | Neutral | Downgrade | Jun 20, 2019 |
| Susquehanna | Neutral | Neutral | Maintain | Oct 25, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Jul 27, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Berenberg | Hold | Sell | Upgrade | Dec 18, 2017 |
| Societe Generale | Hold | Sell | Upgrade | Feb 28, 2017 |
| Tigress Financial | Neutral | Buy | Downgrade | Jul 11, 2016 |
| Nomura | Sell | Reduce | Maintain | Apr 20, 2015 |
Named analyst price targets
Upside is calculated against the persisted previous close $183.91. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $225 | $170.25 | +22.3% | Jul 23, 2026 |
| Barclays | Andrew Lazar | $208 | $171.7 | +13.1% | Jul 21, 2026 |
| Jefferies | Analyst unavailable | $190 | $170.27 | +3.3% | Jul 16, 2026 |
| Piper Sandler | Analyst unavailable | $200 | $174.41 | +8.7% | Jul 9, 2026 |
| Evercore ISI | Analyst unavailable | $255 | $191.12 | +38.7% | May 27, 2026 |
| Mizuho Securities | John Baumgartner | $185 | $192.8 | +0.6% | May 20, 2026 |
| D.A. Davidson | Analyst unavailable | $208 | $181.92 | +13.1% | May 4, 2026 |
| Barclays | Analyst unavailable | $220 | $182.34 | +19.6% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $240 | $182.34 | +30.5% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $227 | $188.65 | +23.4% | Apr 23, 2026 |
| Stifel Nicolaus | Matthew Smith | $215 | $191.45 | +16.9% | Apr 21, 2026 |
| Barclays | Analyst unavailable | $225 | $197.93 | +22.3% | Apr 14, 2026 |
| Piper Sandler | Michael Lavery | $249 | $226.94 | +35.4% | Feb 25, 2026 |
| Mizuho Securities | Analyst unavailable | $195 | $226.07 | +6.0% | Feb 24, 2026 |
| Stephens | Analyst unavailable | $260 | $230.61 | +41.4% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $238 | $230.12 | +29.4% | Feb 6, 2026 |
| D.A. Davidson | Brian Holland | $243 | $230.2 | +32.1% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $267 | $231.42 | +45.2% | Feb 6, 2026 |
| Bernstein | Alexia Howard | $250 | $230.98 | +35.9% | Feb 6, 2026 |
| Evercore ISI | David Palmer | $250 | $232.75 | +35.9% | Feb 6, 2026 |
| Stifel Nicolaus | Analyst unavailable | $230 | $224.38 | +25.1% | Feb 6, 2026 |
| UBS | Analyst unavailable | $236 | $224.38 | +28.3% | Feb 6, 2026 |
| Barclays | Andrew Lazar | $240 | $224.38 | +30.5% | Feb 6, 2026 |
| D.A. Davidson | Analyst unavailable | $207 | $194.84 | +12.6% | Feb 2, 2026 |
| Deutsche Bank | Analyst unavailable | $188 | $194.54 | +2.2% | Jan 29, 2026 |
| Morgan Stanley | Megan Alexander Clapp | $214 | $190.67 | +16.4% | Jan 28, 2026 |
| Bernstein | Alexia Howard | $84 | $189.2 | -54.3% | Jan 26, 2026 |
| Barclays | Analyst unavailable | $210 | $198.36 | +14.2% | Jan 16, 2026 |
| UBS | Analyst unavailable | $210 | $195.73 | +14.2% | Jan 14, 2026 |
| Piper Sandler | Analyst unavailable | $213 | $179.28 | +15.8% | Jan 6, 2026 |
| Wells Fargo | Chris Carey | $182 | $182.41 | -1.0% | Jan 5, 2026 |
| Piper Sandler | Analyst unavailable | $193 | $188.16 | +4.9% | Dec 19, 2025 |
| Morgan Stanley | Analyst unavailable | $211 | $181.83 | +14.7% | Dec 15, 2025 |
| Morgan Stanley | Analyst unavailable | $195 | $180.98 | +6.0% | Dec 4, 2025 |
| Jefferies | Analyst unavailable | $181 | $180.63 | -1.6% | Dec 4, 2025 |
| Piper Sandler | Michael Lavery | $180 | $182.66 | -2.1% | Nov 21, 2025 |
| Barclays | Andrew Lazar | $188 | $169.63 | +2.2% | Nov 3, 2025 |
| Evercore ISI | David Palmer | $215 | $167.89 | +16.9% | Oct 31, 2025 |
| Morgan Stanley | Megan Alexander Clapp | $184 | $168.3 | +0.0% | Oct 31, 2025 |
| Stifel Nicolaus | Matthew Smith | $185 | $167.17 | +0.6% | Oct 31, 2025 |
| UBS | Analyst unavailable | $190 | $169.35 | +3.3% | Oct 31, 2025 |
| Stifel Nicolaus | Analyst unavailable | $195 | $181.38 | +6.0% | Oct 24, 2025 |
| Morgan Stanley | Analyst unavailable | $193 | $193.02 | +4.9% | Oct 16, 2025 |
| UBS | Analyst unavailable | $205 | $194.39 | +11.5% | Oct 8, 2025 |
| Goldman Sachs | Leah Jordan | $222 | $190.28 | +20.7% | Sep 16, 2025 |
| Piper Sandler | Michael Lavery | $167 | $187.83 | -9.2% | Sep 9, 2025 |
| D.A. Davidson | Analyst unavailable | $188 | $190.41 | +2.2% | Aug 4, 2025 |
| Piper Sandler | Michael Lavery | $168 | $175.67 | -8.7% | Nov 8, 2024 |
| Stifel Nicolaus | Matthew Smith | $180 | $179.69 | -2.1% | Nov 7, 2024 |
| Piper Sandler | Michael Lavery | $165 | $183.47 | -10.3% | Oct 23, 2024 |
| CFRA | Arun Sundaram | $169 | $183.47 | -8.1% | Oct 22, 2024 |
| Redburn Partners | Bingqing Zhu | $165 | $184.67 | -10.3% | Oct 22, 2024 |
| Jefferies | Rob Dickerson | $163 | $191 | -11.4% | Sep 26, 2024 |
| Barclays | Andrew Lazar | $202 | $195.14 | +9.8% | Sep 24, 2024 |
| Piper Sandler | Michael Lavery | $179 | $201.31 | -2.7% | Sep 17, 2024 |
| Wells Fargo | Chris Carey | $205 | $197.92 | +11.5% | May 6, 2024 |
| Coker Palmer | Thomas Palmer | $204 | $197.92 | +10.9% | May 5, 2024 |
| Wells Fargo | Chris Carey | $200 | $183.31 | +8.7% | Apr 17, 2024 |
| Deutsche Bank | Steve Powers | $197 | $194.19 | +7.1% | Apr 8, 2024 |
| Bernstein | Alexia Howard | $235 | $191.96 | +27.8% | Jan 29, 2024 |
| Morgan Stanley | Pamela Kaufman | $246 | $243.66 | +33.8% | Mar 20, 2023 |
| Craig-Hallum | Anthony Stoss | $129.11 | $233.86 | -29.8% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $230 | $233.05 | +25.1% | Feb 3, 2023 |
| Credit Suisse | Analyst unavailable | $260 | $234.77 | +41.4% | Feb 3, 2023 |
| Wells Fargo | Analyst unavailable | $220 | $227.7 | +19.6% | Jan 3, 2023 |
| Morgan Stanley | Pamela Kaufman | $231 | $234.89 | +25.6% | Dec 20, 2022 |
| UBS | Analyst unavailable | $269 | $236.69 | +46.3% | Dec 8, 2022 |
| Deutsche Bank | Analyst unavailable | $246 | $232.4 | +33.8% | Dec 6, 2022 |
| BNP Paribas | Analyst unavailable | $235 | $218.12 | +27.8% | Nov 15, 2022 |
| Mizuho Securities | Analyst unavailable | $210 | $227.48 | +14.2% | Apr 29, 2022 |
| Morgan Stanley | Analyst unavailable | $222 | $227.2 | +20.7% | Apr 29, 2022 |
| BMO Capital | Analyst unavailable | $255 | $227.48 | +38.7% | Apr 29, 2022 |
| Credit Suisse | Robert Moskow | $227 | $201.88 | +23.4% | Feb 4, 2022 |
| Bank of America Securities | Bryan Spillane | $225 | $201.88 | +22.3% | Feb 4, 2022 |
| Piper Sandler | Michael Lavery | $205 | $203.01 | +11.5% | Feb 3, 2022 |
| Goldman Sachs | Jason English | $227 | $203.01 | +23.4% | Feb 3, 2022 |
| Mizuho Securities | John Baumgartner | $196 | $203.01 | +6.6% | Feb 3, 2022 |
| Morgan Stanley | Pamela Kaufman | $191 | $193.17 | +3.9% | Jan 11, 2022 |
Track every rating change on HSY the moment it posts. Free to start.
Start free